^
BIOMARKER:

EGFR L858R

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
EGFR L858R
Non Small Cell Lung Cancer
KN046
Sensitive
:
C3
ESMO 2022 - 3 weeks - (New C3)
EGFR L858R
Non Small Cell Lung Cancer
EGFR inhibitor
Sensitive
:
C3
J Cancer Res Clin Oncol - 4 weeks - (New C3)
EGFR L858R
Non Small Cell Lung Cancer
Angiogenesis inhibitor
Sensitive
:
C3
Sci Rep - 4 weeks - (New C3)
EGFR L858R
Non Small Cell Lung Cancer
afatinib
Sensitive
:
A1
EGFR L858R
Non Small Cell Lung Cancer
osimertinib
Sensitive
:
A1
EGFR L858R
Non Small Cell Lung Cancer
dacomitinib
Sensitive
:
A1
EGFR L858R
Non Small Cell Lung Cancer
gefitinib
Sensitive
:
A1
EGFR L858R
Non Small Cell Lung Cancer
erlotinib
Sensitive
:
A1
EGFR L858R
Non Small Cell Lung Cancer
erlotinib + ramucirumab
Sensitive
:
A1
EGFR L858R
Lung Non-Squamous Non-Small Cell Cancer
osimertinib
Sensitive
:
A2
EGFR L858R
Non Small Cell Lung Cancer
icotinib
Sensitive
:
B
EGFR L858R
Non Small Cell Lung Cancer
gefitinib + rivoceranib
Sensitive
:
B
EGFR L858R
Lung Non-Squamous Non-Small Cell Cancer
bevacizumab + atezolizumab
Sensitive
:
B
EGFR L858R
Lung Adenocarcinoma
gefitinib
Sensitive
:
B
EGFR L858R
Lung Adenocarcinoma
erlotinib
Resistant
:
B
EGFR L858R
Non Small Cell Lung Cancer
gefitinib + ramucirumab
Sensitive
:
B
EGFR L858R
Lung Non-Small Cell Squamous Cancer
erlotinib
Sensitive
:
B
EGFR L858R
Lung Non-Small Cell Squamous Cancer
EGFR inhibitor
Sensitive
:
B
EGFR L858R
Non Small Cell Lung Cancer
aumolertinib
Sensitive
:
B
EGFR L858R
Lung Adenocarcinoma
afatinib
Sensitive
:
B
EGFR L858R
Non Small Cell Lung Cancer
furmonertinib
Sensitive
:
B
EGFR L858R
Thyroid Gland Anaplastic Carcinoma
erlotinib
Sensitive
:
C1
EGFR L858R
Lung Adenocarcinoma
osimertinib
Sensitive
:
C1
EGFR L858R
Lung Cancer
gefitinib
Sensitive
:
C1
EGFR L858R
Lung Cancer
osimertinib
Resistant
:
C1
EGFR L858R
Non Small Cell Lung Cancer
bevacizumab
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
osimertinib + ABT 263
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
osimertinib + gefitinib
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
anlotinib + icotinib
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
amivantamab-vmjw
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
EGF816
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
osimertinib + savolitinib
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
cisplatin + erlotinib + docetaxel
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
rociletinib
Sensitive
:
C2
EGFR L858R
Non Small Cell Lung Cancer
amivantamab-vmjw + lazertinib
Sensitive
:
C2